Human Papillomavirus Vaccination Knowledge, Barriers, and Recommendations Among Healthcare Provider Groups in the Western United States

Shauna Ayres, Alexandra Gee, Seungmin Kim, Mia Hashibe, Aisha Praag, Danielle Kaiser, Chun-Pin Chang, Heather M Brandt, Deanna Kepka, Shauna Ayres, Alexandra Gee, Seungmin Kim, Mia Hashibe, Aisha Praag, Danielle Kaiser, Chun-Pin Chang, Heather M Brandt, Deanna Kepka

Abstract

This study compared human papillomavirus (HPV) vaccination occurrences on the same day as provider recommendations at clinics in the Western United States stratified by healthcare provider groups. In addition, the relationships between provider groups' perceived challenges associated with HPV vaccination, HPV vaccination knowledge, HPV recommendation practices, and same-day HPV vaccinations and recommendations are described. Eligible participants included pediatric healthcare providers and staff with influence on patient/parental-level decisions regarding HPV vaccination. Participants filled out a 40-question survey. Results for study participants (N = 99) showed providers reported a higher number of challenges limiting HPV vaccination, higher HPV vaccination knowledge, and more favorable HPV vaccination recommendation practices compared to other healthcare team members (OTM) suggesting providers may have a better overall understanding of the HPV vaccination climate than OTMs. Clinics should examine OTMs' training, expectations, and opportunities to increase the frequency and strength of HPV vaccination recommendations to adolescent patients and parents.

Keywords: HPV vaccine; Provider recommendation; Rural health.

© 2021. American Association for Cancer Education.

References

    1. Allen JD, Othus MK, Shelton RC, Li Y, Norman N, Tom L, & del Carmen MG (2010). Parental decision making about the HPV vaccine. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 19(9), 2187–2198. 10.1158/1055-9965.EPI-10-0217
    1. Askelson NM, Ryan G, Seegmiller L, Pieper F, Kintigh B, & Callaghan D (2019). Implementation Challenges and Opportunities Related to HPV Vaccination Quality Improvement in Primary Care Clinics in a Rural State. Journal of community health, 44(4), 790–795. 10.1007/s10900-019-00676-z
    1. Berkowitz Z, Malone M, Rodriguez J, & Saraiya M (2015). Providers’ beliefs about the effectiveness of the HPV vaccine in preventing cancer and their recommended age groups for vaccination: Findings from a provider survey, 2012. Preventive medicine, 81, 405–411. 10.1016/j.ypmed.2015.10.007
    1. Blasi PR, King D, & Henrikson NB (2015). HPV Vaccine Public Awareness Campaigns: An Environmental Scan. Health Promotion Practice, 16(6), 897–905. 10.1177/1524839915596133
    1. Blumling AA, Thomas TL, & Stephens DP (2013). Researching and respecting the intricacies of isolated communities. Online journal of rural nursing and health care: the official journal of the Rural Nurse Organization, 13(2).
    1. Casey MM, Thiede Call K, & Klingner JM (2001). Are rural residents less likely to obtain recommended preventive healthcare services?. American journal of preventive medicine, 21(3), 182–188. 10.1016/s0749-3797(01)00349-x
    1. Centers for Disease Control and Prevention. (2019, August 22). Cancers Associated with Human Papillomavirus, United States—2012–2016.
    1. Daley MF, Crane LA, Markowitz LE, Black SR, Beaty BL, Barrow J, Babbel C, Gottlieb SL, Liddon N, Stokley S, Dickinson LM, & Kempe A (2010). Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure. Pediatrics, 126(3), 425–433. 10.1542/peds.2009-3500
    1. Elam-Evans LD, Yankey D, Singleton JA, et al. (2020). National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2019. MMWR Morb Mortal Wkly Rep, 69, 1109–1116. 10.15585/mmwr.mm6933a1
    1. Hart LG, Larson EH, & Lishner DM (2005). Rural definitions for health policy and research. American journal of public health, 95(7), 1149–1155. 10.2105/AJPH.2004.042432
    1. Head KJ, Biederman E, Sturm LA, & Zimet GD (2018). A retrospective and prospective look at strategies to increase adolescent HPV vaccine uptake in the United States. Human vaccines & immunotherapeutics, 14(7), 1626–1635. 10.1080/21645515.2018.1430539
    1. Holman DM, Benard V, Roland KB, Watson M, Liddon N, & Stokley S (2014). Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA pediatrics, 168(1), 76–82. 10.1001/jamapediatrics.2013.2752
    1. Hughes CC, Jones AL, Feemster KA, & Fiks AG (2011). HPV vaccine decision making in pediatric primary care: a semi-structured interview study. BMC pediatrics, 11, 74. 10.1186/1471-2431-11-74
    1. Landis K, Bednarczyk RA, & Gaydos LM (2018). Correlates of HPV vaccine initiation and provider recommendation among male adolescents, 2014 NIS-Teen. Vaccine, 36(24), 3498–3504. 10.1016/j.vaccine.2018.04.075
    1. McRee AL, Gilkey MB, & Dempsey AF (2014). HPV vaccine hesitancy: findings from a statewide survey of health care providers. Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners, 28(6), 541–549. 10.1016/j.pedhc.2014.05.003
    1. Meites E, Kempe A, Markowitz LE (2016). Use of a 2-dose schedule for human papillomavirus vaccination - Updated recommendations of the Advisory Committee on Immunization Practices. MMWR. Morb. Mortal. Wkly. Rep,. 65, 1405–1408. 10.15585/mmwr.mm6549a5
    1. Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE (2019). Human papillomavirus vaccination for adults: Updated recommendations of the Advisory Committee on Immunization Practices. MMWR. Morb. Mortal. Wkly. Rep, 68, 698–702. 10.15585/mmwr.mm6832a3
    1. Mohanty S, Leader AE, Gibeau E, & Johnson C (2018). Using Facebook to reach adolescents for human papillomavirus (HPV) vaccination. Vaccine, 36(40), 5955–5961.
    1. Newcomer SR, Caringi J, Jones B, Coyle E, Schehl T, Daley MF (2020). A mixed-methods analysis of barriers to and facilitators of human papillomavirus vaccination among adolescents in Montana. Public Health Rep. In press.
    1. Nyhan B, Reifler J, Richey S, & Freed GL (2014). Effective messages in vaccine promotion: a randomized trial. Pediatrics, 133(4), e835–e842.
    1. Peterson CE, Silva A, Holt HK, Balanean A, Goben AH, Dykens A (2020). Barriers and facilitators to HPV vaccine uptake among US rural populations: a scoping review. Cancer Causes Control, 31, 801–814. 10.1007/s10552-020-01323-y
    1. Reiter PL, Brewer NT, Gottlieb SL, McRee AL, & Smith JS (2009). Parents’ health beliefs and HPV vaccination of their adolescent daughters. Social science & medicine (1982), 69(3), 475–480. 10.1016/j.socscimed.2009.05.024
    1. Reveal JM. Increasing HPV vaccine provider recommendations in a rural southwest clinic. ProQuest Dissertations Publishing; 2016.
    1. Roberts JR, Dawley E, Garbe C, Cooper T, O’Brien B, Madden C, & Darden PM (2020). A survey of office practice: Parents, front office staff, nurses and clinicians hold disparate views on adolescent vaccines. Vaccine.
    1. Rosenthal SL, Weiss TW, Zimet GD, Ma L, Good MB, & Vichnin MD (2011). Predictors of HPV vaccine uptake among women aged 19–26: importance of a physician’s recommendation. Vaccine, 29(5), 890–895. 10.1016/j.vaccine.2009.12.063
    1. Shell R, & Tudiver F (2004). Barriers to cancer screening by rural Appalachian primary care providers. The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association, 20(4), 368–373. 10.1111/j.1748-0361.2004.tb00051.x
    1. Topazian HM, Dizon AM, Di Bona VL, Levitz L, Ramos S, Morgan K, Kim CJ, Richter K, De Sanjose S, & Smith JS (2019). Adolescent providers’ knowledge of human papillomavirus vaccination age guidelines in five countries. Human vaccines & immunotherapeutics, 15(7–8), 1672–1677. 10.1080/21645515.2018.1558688
    1. United States Department of Agriculture. (2010). Rural-Urban Commuting Areas Codes (RUCA).
    1. Vadaparampil ST, Kahn JA, Salmon D, Lee JH, Quinn GP, Roetzheim R, Bruder K, Malo TL, Proveaux T, Zhao X, Halsey N, & Giuliano AR (2011). Missed clinical opportunities: provider recommendations for HPV vaccination for 11–12 year old girls are limited. Vaccine, 29(47), 8634–8641. 10.1016/j.vaccine.2011.09.006
    1. Vanderpool RC, Stradtman LR, Brandt HM (2019). Policy opportunities to increase HPV vaccination in rural communities. Hum. Vaccin. Immunother, 15, 1527–1532. 10.1080/21645515.2018.1553475
    1. Walker TY, Elam-Evans LD, Singleton JA, et al. (2017, August 25) National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2016. MMWR Morb Mortal Wkly Rep 2017; 66:874–882.
    1. Williams CL, Walker TY, Elam-Evans LD, Yankey D, Fredua B, Saraiya M, Stokley S (2020). Factors associated with not receiving HPV vaccine among adolescents by metropolitan statistical area status, United States, National Immunization Survey-Teen, 2016–2017. Hum. Vaccin. Immunother., 16, 562–572. 10.1080/21645515.2019.1670036
    1. Yabroff KR, Lawrence WF, King JC, Mangan P, Washington KS, Yi B, Kerner JF, & Mandelblatt JS (2005). Geographic disparities in cervical cancer mortality: what are the roles of risk factor prevalence, screening, and use of recommended treatment?. The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association, 21(2), 149–157. 10.1111/j.1748-0361.2005.tb00075.x
    1. Ylitalo KR, Lee H, & Mehta NK (2013). Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US National Immunization Survey. American journal of public health, 103(1), 164–169. 10.2105/AJPH.2011.300600

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner